Figure 5.
Figure 5. Antifibrin(ogen) immunostaining of heart sections at various times after LPS administration for WT and EPCRδ/δ mice, respectively. (A-B) WT and EPCRδ/δ control heart tissue (time = 0), respectively; (C-D), WT and EPCRδ/δ heart tissue, respectively, at 6 hours after LPS; (E-F), WT and EPCRδ/δ heart tissue, respectively, at 24 hours after LPS; (G-H), WT and EPCRδ/δ mice, respectively, at 48 hours after LPS. Microscopy was performed as described in Figure 4.

Antifibrin(ogen) immunostaining of heart sections at various times after LPS administration for WT and EPCRδ/δ mice, respectively. (A-B) WT and EPCRδ/δ control heart tissue (time = 0), respectively; (C-D), WT and EPCRδ/δ heart tissue, respectively, at 6 hours after LPS; (E-F), WT and EPCRδ/δ heart tissue, respectively, at 24 hours after LPS; (G-H), WT and EPCRδ/δ mice, respectively, at 48 hours after LPS. Microscopy was performed as described in Figure 4.

Close Modal

or Create an Account

Close Modal
Close Modal